ekonominyheter

TranslateRSSMobil
Actavis to Buy Allergan for $66 Billion

Actavis to Buy Allergan for $66 Billion

Wall Street Journal 17/11 12:49

Actavis agreed to pay $66 billion in cash and stock for Allergan in a deal that appears to have thwarted a hostile takeover of the Botox maker by Valeant, Bill Ackman.

Till artikeln

Ekonomi Nyheter .se - Innehåll

 

 

 

 

DMCA.com Protection Status